Assessing the mortality burden after acute myocardial infarction in systemic lupus erythematosus: insights from the MINAP Registry

Clicks: 1
ID: 320693
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #43 of 197 articles by views in Lara D. Veeken

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 197 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objectives Acute myocardial infarction (AMI) is a leading cause of mortality globally. Although SLE is known to increase the risk of AMI, its impact on long-term outcomes following AMI in contemporary populations remains poorly defined. To determine whether individuals with SLE experience higher long-term mortality after AMI compared with those without SLE. Methods Adults hospitalised with AMI between January 2005 and March 2019 were identified from the Myocardial Ischaemia National Audit Project registry and linked with Hospital Episode Statistics and Office for National Statistics mortality records. Long-term all-cause and cardiovascular mortality were assessed up to 5 years post-AMI. Results Of 784,091 patients with AMI, 715 (0.1%) had a diagnosis of SLE. Patients with SLE were younger (median 63.9 vs. 70.3 years; P<0.001) and more often female (76% vs. 34%; P<0.001). Adjusted all-cause mortality was higher among those with SLE from 30 days (HR 1.62; 95% CI 1.23, 2.12; P=0.001) to 5 years (HR 1.84; 95% CI 1.63, 2.09; P<0.001). Adjusted cardiovascular mortality was similarly elevated at 30 days (HR 1.63; 95% CI 1.20–2.21; P=0.002) and 5 years (HR 1.75; 95% CI 1.46–2.10; P<0.001). Conclusions Individuals with SLE have a persistently higher risk of all-cause and cardiovascular mortality following AMI, despite being younger and having less traditional cardiovascular comorbidities. These findings highlight SLE as an independent determinant of adverse post-AMI outcomes and support aggressive, guideline-directed secondary prevention in this high-risk population.
Reference Key
openalex_W7168041364 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors K Kermani, A Cole, N Weight, Muhammad Rashid, M A M A S Mamas
Journal Lara D. Veeken
Year 2026
DOI
10.1093/rheumatology/keag365
URL
https://doi.org/10.1093/rheumatology/keag365
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.